Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The . gov means it’s official. Federal government websites often end in . gov or . mil VSports app下载. Before sharing sensitive information, make sure you’re on a federal government site. .

Https

The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. V体育官网.

. 2021 Mar;156(6):979-987.
doi: 10.1111/jnc.15114. Epub 2020 Jul 20.

Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals

Adam P Gunn  1   2 , Bruce X Wong  3 , Catriona McLean  4 , Chris Fowler  1 , Peter J Barnard  5 , James A Duce  1   3 , Blaine R Roberts  1   6   7 ; AIBL Research Group
Affiliations

V体育官网入口 - Increased glutaminyl cyclase activity in brains of Alzheimer's disease individuals

Adam P Gunn et al. J Neurochem. 2021 Mar.

Abstract

Glutaminyl cyclases (QC) catalyze the formation of neurotoxic pGlu-modified amyloid-β peptides found in the brains of people with Alzheimer's disease (AD). Reports of several-fold increases in soluble QC (sQC) expression in the brain and peripheral circulation of AD individuals has prompted the development of QC inhibitors as potential AD therapeutics VSports手机版. There is, however, a lack of standardized quantitative data on QC expression in human tissues, precluding inter-laboratory comparison and validation. We tested the hypothesis that QC is elevated in AD tissues by quantifying levels of sQC protein and activity in post-mortem brain tissues from AD and age-matched control individuals. We found a modest but statistically significant increase in sQC protein, which paralleled a similar increase in enzyme activity. In plasma samples sourced from the Australian Imaging, Biomarker and Lifestyle study we determined that QC activity was not different between the AD and control group, though a modest increase was observed in female AD individuals compared to controls. Plasma QC activity was further correlated with levels of circulating monocytes in AD individuals. These data provide quantitative evidence that alterations in QC expression are associated with AD pathology. .

Keywords: Alzheimer's disease; amyloid-β; glutaminyl cyclase; monocyte; pyroglutamate. V体育安卓版.

PubMed Disclaimer

V体育安卓版 - References

REFERENCES

    1. Abraham, G. N., & Podell, D. N. (1981). Pyroglutamic acid. Non-metabolic formation, function in proteins and peptides, and characteristics of the enzymes effecting its removal. Molecular and Cellular Biochemistry, 38(Spec No), 181-190.
    1. Agostini, M., & Fasolato, C. (2016). When, where and how? Focus on neuronal calcium dysfunctions in Alzheimer's disease. Cell Calcium, 60, 289-298. https://doi.org/10.1016/j.ceca.2016.06.008 (VSports最新版本)
    1. Anand, A., Patience, A. A., Sharma, N., & Khurana, N. (2017). The present and future of pharmacotherapy of Alzheimer's disease: A comprehensive review. European Journal of Pharmacology, 815, 364-375. https://doi.org/10.1016/j.ejphar.2017.09.043 (V体育平台登录)
    1. Bridel, C., Hoffmann, T., Meyer, A., Durieux, S., Koel-Simmelink, M. A., Orth, M., … Teunissen, C. E. (2017). Glutaminyl cyclase activity correlates with levels of Abeta peptides and mediators of angiogenesis in cerebrospinal fluid of Alzheimer's disease patients. Alzheimer's Research and Therapy, 9, 38.
    1. Brooks, A. F., Jackson, I. M., Shao, X., Kropog, G. W., Sherman, P., Quesada, C. A., & Scott, P. J. (2015). Synthesis and evaluation of [11C]PBD150, a radiolabeled glutaminyl cyclase inhibitor for the potential detection of Alzheimer's disease prior to amyloid beta aggregation. Medchemcomm, 6, 1065-1068.

Publication types

V体育官网 - MeSH terms

Substances